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[]Eradication strategies for early Pseudomonas aeruginosa: a 
meta-analysis 
D.M. Wood 1 , A.R. Smyth 2. 1Department of Child Health, Queen~' Medical 
Centre, University Hospital 2Department of Paediatrics, Nottingham City 
Hospital Nottingham, UK 
Aims: To determine whether antibiotic treatment of early/~ aeruginosa infection 
in children and adults with cystic fibrosis eradicates the organism and improves 
clinical and microbiological outcome. 
Methods: A systematic review and meta-analysis of relevant rials identified 
by searching the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials 
Register. We included randomised controlled trials of people with cystic fibrosis, 
in whom 1~ aeruginosa had recently been isolated from respiratory secretions. We 
compared combinations of inhaled, oral or intravenous antibiotics with placebo 
or usual treatment (or both) or other combinations of inhaled, oral or intravenous 
antibiotics. We excluded non-randomised trials, cross-over t ials, and those utilising 
historical controls. Both authors independently assessed selected trials, assessed 
methodological quality and extracted ata. 
Main results: The search identified 15 trials. Three trials (69 participants) were 
eligible for inclusion. There is evidence from two randomised controlled trials, of 
questionable methodological quality, that treatment of early le aeruginosa infection 
with inhaled tobramycin results in microbiological eradication of the organism from 
respiratory secretions more often than placebo and that this effect may persist for up 
to 12 months, however incomplete data from one of the trials precludes an accurate 
analysis. 
One randomised controlled trial of oral ciprofloxacin and nebulised colisitin versus 
usual treatment was identified. The results suggested treatment of early infection 
results in microbiological eradication of /~ aeruginosa more often than usual 
treatment, after two years, OR 0.12 (95% CI 0.02 to 0.79) 
Conclusions: From the three trials included in this review, there is some evidence 
that antibiotic treatment of early le aeruginosa results in short-term eradication but 
it remains uncertain whether there is clinical benefit o people with cystic fibrosis. 
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Introduction; Pseudomonas aeruginosa (PA) colonization in cystic fibrosis (CF) 
patients has a negative ffect on pulmonary function and is a predictor of poor 
survival. There is increasing evidence that early treatment of PA infection could 
delay chronic infection. 
Aims; 
1. To evaluate the effect of early treatment of first PA infection with oral 
ciprofloxacin (20 40mg/kg/day in two doses, for only 21 days) and inhaled 
tobramycin (300 mg twice daily in 3 cycles of 28 days on and off) according to 
the Spanish protocol (Canton et al., 2005); 
2. To determine the time that the patient remains clear after treatment. 
Methods; We included patients with the first PA isolation between July 2002 
to July 2004. All the patients were treated as mentioned above. Samples for 
microbiology analysis were taken monthly. PA was considered eradicated when 
respiratory cultures were negative over one year after the first isolation. 
Results; Eighteen patients received treatment (8 females and 10 males; 1 13 years, 
mean age: 7.5 years). All the patients had a negative culture after the first month 
of therapy. The mean time of PA free period was 15.1 months (3 36 months). 
Fourteen patients were successfully treated, as 1 year of PA-free was documented 
by negative cultures. No new chronic colonization or resistance was detected. 
Conclusions; Early combined treatment of first PA isolation was effective to 
decrease the prevalence of chronic colonization with PA. 
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Introduction; Aggressive treatment of"first growth" Pseudomonas eruginosa (Pa) 
infection in CF patients attending our clinic has led to a decrease in chronic 
colonization with Pa from 44% of our pediatric linic patients in 1994 to 18% 
in 2005. We have previously reported on the clinical effects of this policy, for 
example in improving the secular decline in pulmonary function in clinic patients. 
Aim; We now report he effect on hospital and antibiotic costs for our patients as 
a result of this approach. 
Subjects and Methods; CF patients attending our clinic (n 140, ages 0 18yr) 
have sputum or throat cultures taken at each clinic visit. Patients with a "first" 
positive culture of Pa are treated with 14 days iv Tobramycin and Piperacillin 
followed by 14 days p.o. Ciprofloxacin and 3 6 months inhaled Colymycin. 
Results; The decline in Pa infection has had an economic impact, decreasing 
hospital and antibiotic costs. Although the total number of CF clinic patients has 
increased, total days spent in hospital has declined, specifically due to a decrease 
in admissions resulting from pulmonary exacerbations a sociated with Pa; hospital 
and home i.v. antibiotic use has declined; as have also the requirements for inhaled 
(anti-Pseudomonal) ntibiotics. 
Conclusion; Early aggressive treatment of "first growth" Pa can decrease the 
economic osts of CF management, as well as conferring clinical benefit. 
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1• Early eradication therapy for Pseudomonas aeruginosa: impact of 
effective communication between the laboratory and clinical staff 
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Aims: Early eradication therapy may delay the onset of chronic infection with 
Pseudomonas aeruginosa in patients with CE We assessed the impact of written 
and verbal flagging of laboratory reports on the time to commencement of antibiotic 
therapy after isolation of P aeruginosa. 
Methods: The study was conducted at the Regional Paediatric CF Unit in Leeds, 
UK. We reviewed all episodes of eradication therapy between 1st January 2000 
and 31st December 2004. Between 2000 and mid-2001 the laboratory did not 
flag P aeruginosa s being from patients who qualified for eradication therapy. 
Between mid-2001 to mid-2004 awritten flag was placed on the report o identify 
qualification for eradication therapy. From mid-2004 this was further enhanced by 
an additional telephone call to the clinical team. The time between issuing the 
laboratory report and commencement of eradication therapy was determined for 
each calendar year. 
Results: Complete data was available on 223 episodes of eradication therapy in 
118 patients. Flagging reports reduced the mean time to commencement of herapy 
from 14.7 days in 2000 to 8.1 days in 2004. Overall the mean time to commencing 
therapy after flagged reports was 10.8 days compared to 15 days for non-flagged 
reports (p 0.002). 
Conclusions: The use of flagged reports resulted in faster commencement of 
eradication therapy for early P aeruginosa colonization. Larger studies are needed 
to assess the clinical impact of this development. 
